Psych FI retweeted
Congratulations to Dr. Fred Barrett (@FredBarrettPhD) who was named the Oliver Lee McCabe III, Ph.D. Professor in the Neuropsychopharmacology of Consciousness!
An endowed professorship is a distinct honor in academia and is a testament to Dr. Barrett's hard work, leadership, and dedication to understanding the role of psychedelics in the brain, mental health, and consciousness. This professorship pays homage to Dr. Oliver Lee McCabe III who conducted pioneering investigations using LSD for the treatment of addictions in the 1970s, and reflects a long-term commitment to deepening the scientific investigation of psychedelics.
Psych FI retweeted
Roland Griffiths and his tremendous contributions not only psychedelics and research, but also to society, remain ever-admired.
This article in the Journal of Psychoactive Drugs is a reminder of this: tandfonline.com/doi/full/10.…
Psych FI retweeted
Last friday 26th April was the 5th anniversary of the funding of our centre, the world’s first focused on psychedelic science.
We must thank our founder @RCarhartHarris, @ProfDavidNutt, @DavidErritzoe and all the amazing team in the group! 🍄 So much was produced in 5 years.
Psych FI retweeted
This article attempts to quantify the risks and benefits of psychedelics and considers how they may change in the future as better designed studies with larger and more heterogenous samples emerge. The early state of this research calls for caution about predicting the long-term reproducibility and generalizability of psychedelic treatments for depression. Balanced science communication is critical for promoting public understanding of the risks and benefits of psychedelics and avoiding overly pessimistic or overly optimistic predictions mdpi.com/2813-1851/3/2/14
@r_ehrenkranz @sdpnayak @MariannaGrazz @ExistWell
Excited to share our new publication ‘Mind the Psychedelic Hype’! We review the risks, benefits, and effect sizes of psychedelics as a treatment for depression in comparison to other depression treatments (mdpi.com/2813-1851/3/2/14)
Psych FI retweeted
Ayahuasca is a plant-based psychedelic drug. Research shows that the ayahuasca experience might act much like an intense form of psychotherapy and might have a link to improvements in some psychiatric symptoms. wb.md/49FMw3d
Psych FI retweeted
Researchers at the Johns Hopkins Center for Psychedelic & Consciousness Research (CPCR) are seeking volunteers for a 5-10 minute survey study about psychedelic experiences among veterans. They are particularly interested in veterans with therapy/medicine experience(s) with Psilocybin and MDMA. jhmi.co1.qualtrics.com/jfe/f…
Psych FI retweeted
Psychedelic experiences have real risks in recreational settings and adverse events can and do occur even in research and clinical contexts. While this information was primary for decades, the press around the positive potential of psychedelics in recent years leads us to issues this reminder. Please share this video widely to help get the word out: youtube.com/watch?v=xUS2I8PN…
Psych FI retweeted
Education around harm reduction remains ever-more important.
In one survey, 95.9% of those who used KnowYourStuffNZ's resources claimed to learn something about harm reduction...
...and 53.3% said they've changed their behaviour because of the service.
harmreductionjournal.biomedc…
Psych FI retweeted
A pivotal study explored how patient expectations affect psilocybin therapy outcomes, discovering no significant impact. Interestingly, suggestible individuals showed enhanced benefits, suggesting a unique interplay between mindset and psychedelic… dlvr.it/T4Dls9
Psych FI retweeted
Top Federal Drug Agency Cites Marijuana And Psychedelics Research Efforts To Justify Congressional Funding: "NIDA is increasing support for therapies using psychedelic drugs, such as psilocybin (from 'magic mushrooms') and dissociative drugs."
marijuanamoment.net/top-fede…
Psych FI retweeted
We are thrilled to announce that Dr. Albert Garcia-Romeu (@AlChemical77) has been appointed as Associate Director of the CPCR and the Susan Hill Ward Professor in Psychedelics and Consciousness. Dr. Garcia-Romeu is a respected and beloved colleague both in the CPCR and the broader fields of psychedelic science and behavioral pharmacology. He is a diligent scientist who has been working tirelessly to explore the boundaries of the indication space that may be amenable to psychedelic therapy. These appointments are a well-earned testament to his achievements, impact, and contribution both within Hopkins and beyond. Congratulations!
Psych FI retweeted
Last week, Dr. Lauren Atlas @laurenatlas from the @NIH, presented research on domain-general and domain specific mechanisms of expectancy-based pain modulation to the CPCR! Thank you so much for presenting and the work you do!
Psych FI retweeted
From John Hopkins Medicine, "researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month." - bit.ly/3InWAm8
Research of integrative approaches to mental health and well-being is on the rise!
Psych FI retweeted
1997 Krupitsky article on #ketamine therapy for alcohol use disorder.
1997!!! “Total abstinence for more than one year was observed in 66% alcoholic patients in the KPT group, compared to 24% of the conventional treatment control group (p < 0.01).” pubmed.ncbi.nlm.nih.gov/9250…
Psych FI retweeted
"Psychedelic Research as a Career Path: A Roundtable Discussion with Early Career Researchers in the Field"
@NL_Mason and I led a discussion on "how to become a psychedelic researcher" with current graduate and medical students studying psychedelics
liebertpub.com/doi/abs/10.10…
Psych FI retweeted
Excited to share our research on #psychedelics this week at the International Society for Research on Psychedelics in New Orleans!
@DocDurDur @n_sepeda @SeanPGoldy @winstonian3 @BWe1ss @AlChemical77 @FredBarrettPhD @CeydaSayali @PraachiTiwari @sdpnayak @JRichardPhD @ExistWell
Psych FI retweeted
CPCR Faculty @BWe1ss and colleagues published "Ayahuasca in the treatment of posttraumatic stress disorder” and showed findings that should aid in providing additional data to support the use of psychedelic substances to better address significant mental health issues.
Psych FI retweeted
Interviews with clinicians reveal potential benefits of MDMA-assisted therapy for Borderline Personality Disorder (BPD), suggesting similarities with PTSD treatment. The study, published in the Journal of Psychedelic Studies, calls for further research… dlvr.it/T2NYTf
Psych FI retweeted
Psychedelic St Valentine? Planning to take MDMA, a psychedelic drug/attend a psychedelic retreat with your romantic partner and want to help psychedelic research?
Imperial College London is now investigating the long-term effects of taking psychedelics, MDMA, ketamine, 2C-B, etc, in romantic couples, from intimacy to attachment styles and sexual satisfaction. Click here to know more and sign up:
survey.alchemer.eu/s3/906173…
This study is for people in a romantic relationship, however you can also participate by yourself if your partner do not want to participate. One member of the couple must enrol in the study first before receiving a unique link to share the study with their partner. You will be asked to select the date of your experience and you will receive questionnaires at 5 different timepoints.
(from @tommaso_barba)

























